Pulmatrix, Inc. (PULM)
NASDAQ·Healthcare·Biotechnology
$1.30
-2.26%
Mkt Cap $7.49M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 26, 2026 | — | — | — | — | -$0.25 | — | — | — |
| Q4 2025 Oct 16, 2025 | — | — | — | — | -$0.24 | — | — | — |
| Q3 2025 Aug 6, 2025 | — | — | — | — | -$0.42 | — | — | — |
| Q2 2025 May 15, 2025 | — | — | — | — | -$0.50 | — | — | — |
| Q1 2025 Mar 21, 2025 | — | $3.00K | — | — | -$0.54 | — | — | — |
| Q4 2024 Nov 8, 2024 | — | $366.00K | — | — | -$0.71 | — | — | — |
| Q3 2024 Aug 13, 2024 | $2.20M | $1.55M | -29.52% | — | -$0.87 | — | — | — |
| Q2 2024 May 10, 2024 | $2.20M | $5.88M | +167.26% | — | $0.23 | — | — | — |
| Q1 2024 Mar 28, 2024 | $1.77M | $2.20M | +24.41% | -$1.04 | -$0.57 | +45.19% | — | — |
| Q4 2023 Nov 9, 2023 | $1.77M | $1.75M | -0.96% | -$1.05 | -$1.03 | +1.90% | — | — |
| Q3 2023 Aug 10, 2023 | $1.51M | $1.84M | +21.80% | -$1.23 | -$1.04 | +15.45% | — | — |
| Q2 2023 May 12, 2023 | — | $1.50M | — | — | -$1.22 | — | — | — |
| Q1 2023 Mar 30, 2023 | $1.87M | $1.71M | -8.66% | -$1.44 | -$1.14 | +20.83% | — | — |
| Q4 2022 Nov 10, 2022 | $1.16M | $1.87M | +61.38% | -$1.51 | -$1.45 | +3.97% | — | — |
| Q3 2022 Aug 8, 2022 | $1.16M | $1.33M | +14.74% | -$1.51 | -$1.36 | +9.93% | — | — |
| Q2 2022 May 12, 2022 | $1.07M | $1.16M | +8.51% | -$1.41 | -$1.51 | -7.09% | — | — |
| Q1 2022 Mar 29, 2022 | $1.18M | $456.00K | -61.22% | -$1.60 | -$2.43 | -51.88% | — | — |
| Q4 2021 Nov 10, 2021 | $763.57K | $1.07M | +40.00% | -$1.40 | -$1.80 | -28.57% | — | — |
| Q3 2021 Aug 10, 2021 | $2.75M | $2.25M | -18.18% | -$1.80 | -$1.40 | +22.22% | — | — |
| Q2 2021 May 11, 2021 | $1.53M | $1.39M | -9.09% | -$2.00 | -$1.80 | +10.00% | — | — |